Abstract
Pancreatic cancer remains as one of the most deadly cancers, and responds poorly to current therapies. The prognosis is extremely poor, with a 5-year survival of less than 5%. Therefore, search for new effective therapeutic drugs is of pivotal need and urgency to improve treatment of this incurable malignancy. Synthetic alkyl-lysophospholipid analogs (ALPs) constitute a heterogeneous group of unnatural lipids that promote apoptosis in a wide variety of tumor cells. In this study, we found that the anticancer drug edelfosine was the most potent ALP in killing human pancreatic cancer cells, targeting endoplasmic reticulum (ER). Edelfosine was taken up in significant amounts by pancreatic cancer cells and induced caspase- and mitochondrial-mediated apoptosis. Pancreatic cancer cells show a prominent ER and edelfosine accumulated in this subcellular structure, inducing a potent ER stress response, with caspase-4, BAP31 and c-Jun NH2-terminal kinase (JNK) activation, CHOP/GADD153 upregulation and phosphorylation of eukaryotic translation initiation factor 2 α-subunit that eventually led to cell death. Oral administration of edelfosine in xenograft mouse models of pancreatic cancer induced a significant regression in tumor growth and an increase in apoptotic index, as assessed by TUNEL assay and caspase-3 activation in the tumor sections. The ER stress-associated marker CHOP/GADD153 was visualized in the pancreatic tumor isolated from edelfosine-treated mice, indicating a strong in vivo ER stress response. These results suggest that edelfosine exerts its pro-apoptotic action in pancreatic cancer cells, both in vitro and in vivo, through its accumulation in the ER, which leads to ER stress and apoptosis. Thus, we propose that the ER could be a key target in pancreatic cancer, and edelfosine may constitute a prototype for the development of a new class of antitumor drugs targeting the ER.
Similar content being viewed by others
References
Alvarez J, Montero M . (2002). Measuring [Ca2+] in the endoplasmic reticulum with aequorin. Cell Calcium 32: 251–260.
Ausili A, Torrecillas A, Aranda FJ, Mollinedo F, Gajate C, Corbalan-Garcia S et al. (2008). Edelfosine is incorporated into rafts and alters their organization. J Phys Chem B 112: 11643–11654.
Breckenridge DG, Stojanovic M, Marcellus RC, Shore GC . (2003). Caspase cleavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome c release to the cytosol. J Cell Biol 160: 1115–1127.
Busto JV, Del Canto-Janez E, Goni FM, Mollinedo F, Alonso A . (2008). Combination of the anti-tumour cell ether lipid edelfosine with sterols abolishes haemolytic side effects of the drug. J Chem Biol 1: 89–94.
Busto JV, Sot J, Goni FM, Mollinedo F, Alonso A . (2007). Surface-active properties of the antitumour ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (edelfosine). Biochim Biophys Acta 1768: 1855–1860.
Carracedo A, Gironella M, Lorente M, Garcia S, Guzman M, Velasco G et al. (2006). Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes. Cancer Res 66: 6748–6755.
Cunha DA, Hekerman P, Ladriere L, Bazarra-Castro A, Ortis F, Wakeham MC et al. (2008). Initiation and execution of lipotoxic ER stress in pancreatic beta-cells. J Cell Sci 121: 2308–2318.
Estella-Hermoso de Mendoza A, Campanero MA, de la Iglesia-Vicente J, Gajate C, Mollinedo F, Blanco-Prieto MJ . (2009). Antitumor alkyl ether lipid edelfosine: tissue distribution and pharmacokinetic behavior in healthy and tumor-bearing immunosuppressed mice. Clin Cancer Res 15: 858–864.
Fonseca SG, Burcin M, Gromada J, Urano F . (2009). Endoplasmic reticulum stress in beta-cells and development of diabetes. Curr Opin Pharmacol 9: 763–770.
Fribley A, Zeng Q, Wang CY . (2004). Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells. Mol Cell Biol 24: 9695–9704.
Gajate C, Barasoain I, Andreu JM, Mollinedo F . (2000a). Induction of apoptosis in leukemic cells by the reversible microtubule-disrupting agent 2-methoxy-5-(2′,3′,4′-trimethoxyphenyl)-2,4,6-cycloheptatrien-1-one: protection by Bcl-2 and Bcl-XL and cell cycle arrest. Cancer Res 60: 2651–2659.
Gajate C, Del Canto-Janez E, Acuna AU, Amat-Guerri F, Geijo E, Santos-Beneit AM et al. (2004). Intracellular triggering of Fas aggregation and recruitment of apoptotic molecules into Fas-enriched rafts in selective tumor cell apoptosis. J Exp Med 200: 353–365.
Gajate C, Fonteriz RI, Cabaner C, Alvarez-Noves G, Alvarez-Rodriguez Y, Modolell M et al. (2000b). Intracellular triggering of Fas, independently of FasL, as a new mechanism of antitumor ether lipid-induced apoptosis. Int J Cancer 85: 674–682.
Gajate C, Gonzalez-Camacho F, Mollinedo F . (2009a). Involvement of raft aggregates enriched in Fas/CD95 death-inducing signaling complex in the antileukemic action of edelfosine in Jurkat cells. PLoS One 4: e5044.
Gajate C, Gonzalez-Camacho F, Mollinedo F . (2009b). Lipid raft connection between extrinsic and intrinsic apoptotic pathways. Biochem Biophys Res Commun 380: 780–784.
Gajate C, Mollinedo F . (2001). The antitumor ether lipid ET-18-OCH3 induces apoptosis through translocation and capping of Fas/CD95 into membrane rafts in human leukemic cells. Blood 98: 3860–3863.
Gajate C, Mollinedo F . (2002). Biological activities, mechanisms of action and biomedical prospect of the antitumor ether phospholipid ET-18-OCH3 (edelfosine), a proapoptotic agent in tumor cells. Curr Drug Metab 3: 491–525.
Gajate C, Mollinedo F . (2007). Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts. Blood 109: 711–719.
Gajate C, Santos-Beneit A, Modolell M, Mollinedo F . (1998). Involvement of c-Jun NH2-terminal kinase activation and c-Jun in the induction of apoptosis by the ether phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine. Mol Pharmacol 53: 602–612.
Hirota M, Kitagaki M, Itagaki H, Aiba S . (2006). Quantitative measurement of spliced XBP1 mRNA as an indicator of endoplasmic reticulum stress. J Toxicol Sci 31: 149–156.
Hitomi J, Katayama T, Eguchi Y, Kudo T, Taniguchi M, Koyama Y et al. (2004). Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Abeta-induced cell death. J Cell Biol 165: 347–356.
Hsu YT, Wolter KG, Youle RJ . (1997). Cytosol-to-membrane redistribution of Bax and Bcl-XL during apoptosis. Proc Natl Acad Sci USA 94: 3668–3672.
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ . (2007). Cancer statistics, 2007. CA Cancer J Clin 57: 43–66.
Klee M, Pimentel-Muinos FX . (2005). Bcl-XL specifically activates Bak to induce swelling and restructuring of the endoplasmic reticulum. J Cell Biol 168: 723–734.
Klimstra DS, Heffess CS, Oertel JE, Rosai J . (1992). Acinar cell carcinoma of the pancreas. A clinicopathologic study of 28 cases. Am J Surg Pathol 16: 815–837.
Kuwana T, Bouchier-Hayes L, Chipuk JE, Bonzon C, Sullivan BA, Green DR et al. (2005). BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol Cell 17: 525–535.
Li D, Xie K, Wolff R, Abbruzzese JL . (2004). Pancreatic cancer. Lancet 363: 1049–1057.
Li J, Lee AS . (2006). Stress induction of GRP78/BiP and its role in cancer. Curr Mol Med 6: 45–54.
Mandic A, Hansson J, Linder S, Shoshan MC . (2003). Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling. J Biol Chem 278: 9100–9106.
Mimnaugh EG, Xu W, Vos M, Yuan X, Isaacs JS, Bisht KS et al. (2004). Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity. Mol Cancer Ther 3: 551–566.
Mollinedo F, de la Iglesia-Vicente J, Gajate C, Estella-Hermoso de Mendoza A, Villa-Pulgarin JA, Campanero MA et al. (2010). Lipid raft-targeted therapy in multiple myeloma. Oncogene 29: 3748–3757.
Mollinedo F, Fernandez M, Hornillos V, Delgado J, Amat-Guerri F, Acuna AU et al. (2011). Involvement of lipid rafts in the localization and dysfunction effect of the antitumor ether phospholipid edelfosine in mitochondria. Cell Death Dis 2: e158.
Mollinedo F, Fernandez-Luna JL, Gajate C, Martin-Martin B, Benito A, Martinez-Dalmau R et al. (1997). Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-XL . Cancer Res 57: 1320–1328.
Mollinedo F, Gajate C . (2006). Fas/CD95 death receptor and lipid rafts: new targets for apoptosis-directed cancer therapy. Drug Resist Updat 9: 51–73.
Mollinedo F, Gajate C . (2010). Lipid rafts and clusters of apoptotic signaling molecule-enriched rafts in cancer therapy. Future Oncol 6: 811–821.
Mollinedo F, Gajate C, Martin-Santamaria S, Gago F . (2004). ET-18-OCH3 (edelfosine): a selective antitumour lipid targeting apoptosis through intracellular activation of Fas/CD95 death receptor. Curr Med Chem 11: 3163–3184.
Montero M, Alvarez J, Scheenen WJ, Rizzuto R, Meldolesi J, Pozzan T . (1997a). Ca2+ homeostasis in the endoplasmic reticulum: coexistence of high and low [Ca2+] subcompartments in intact HeLa cells. J Cell Biol 139: 601–611.
Montero M, Barrero MJ, Alvarez J . (1997b). [Ca2+] microdomains control agonist-induced Ca2+ release in intact HeLa cells. Faseb J 11: 881–885.
Neoptolemos JP, Cunningham D, Friess H, Bassi C, Stocken DD, Tait DM et al. (2003). Adjuvant therapy in pancreatic cancer: historical and current perspectives. Ann Oncol 14: 675–692.
Nieto-Miguel T, Fonteriz RI, Vay L, Gajate C, Lopez-Hernandez S, Mollinedo F . (2007). Endoplasmic reticulum stress in the proapoptotic action of edelfosine in solid tumor cells. Cancer Res 67: 10368–10378.
Nishitoh H, Matsuzawa A, Tobiume K, Saegusa K, Takeda K, Inoue K et al. (2002). ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev 16: 1345–1355.
Oakes SA, Lin SS, Bassik MC . (2006). The control of endoplasmic reticulum-initiated apoptosis by the BCL-2 family of proteins. Curr Mol Med 6: 99–109.
Oyadomari S, Araki E, Mori M . (2002). Endoplasmic reticulum stress-mediated apoptosis in pancreatic beta-cells. Apoptosis 7: 335–345.
Oyadomari S, Mori M . (2004). Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 11: 381–389.
Pique M, Barragan M, Dalmau M, Bellosillo B, Pons G, Gil J . (2000). Aspirin induces apoptosis through mitochondrial cytochrome c release. FEBS Lett 480: 193–196.
Rao RV, Castro-Obregon S, Frankowski H, Schuler M, Stoka V, del Rio G et al. (2002). Coupling endoplasmic reticulum stress to the cell death program. An Apaf-1-independent intrinsic pathway. J Biol Chem 277: 21836–21842.
Riedl SJ, Salvesen GS . (2007). The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol 8: 405–413.
Rizzuto R, Pozzan T . (2006). Microdomains of intracellular Ca2+: molecular determinants and functional consequences. Physiol Rev 86: 369–408.
Ron D, Habener JF . (1992). CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev 6: 439–453.
Skarda JS, Honick AB, Gibbins CS, Josselson AR, Rishi M . (1994). Papillary-cystic tumor of the pancreas in a young woman: fine-needle aspiration cytology, ultrastructure and DNA analysis. Diagn Cytopathol 10: 20–24.
Torrecillas A, Aroca-Aguilar JD, Aranda FJ, Gajate C, Mollinedo F, Corbalan-Garcia S et al. (2006). Effects of the anti-neoplastic agent ET-18-OCH3 and some analogs on the biophysical properties of model membranes. Int J Pharm 318: 28–40.
Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding HP et al. (2000). Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287: 664–666.
van Riel JM, van Groeningen CJ, Pinedo HM, Giaccone G . (1999). Current chemotherapeutic possibilities in pancreaticobiliary cancer. Ann Oncol 10 (Suppl 4): 157–161.
Zaremberg V, Gajate C, Cacharro LM, Mollinedo F, McMaster CR . (2005). Cytotoxicity of an anti-cancer lysophospholipid through selective modification of lipid raft composition. J Biol Chem 280: 38047–38058.
Zerp SF, Vink SR, Ruiter GA, Koolwijk P, Peters E, van der Luit AH et al. (2008). Alkylphospholipids inhibit capillary-like endothelial tube formation in vitro: antiangiogenic properties of a new class of antitumor agents. Anticancer Drugs 19: 65–75.
Zong WX, Li C, Hatzivassiliou G, Lindsten T, Yu QC, Yuan J et al. (2003). Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis. J Cell Biol 162: 59–69.
Zong WX, Lindsten T, Ross AJ, MacGregor GR, Thompson CB . (2001). BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev 15: 1481–1486.
Acknowledgements
This work was supported by grants from Fondo de Investigación Sanitaria and European Commission (FIS-FEDER PS09/01915), Ministerio de Ciencia e Innovación (SAF2008-02251, BFU 2008-01871 and RD06/0020/1037 from Red Temática de Investigación Cooperativa en Cáncer, Instituto de Salud Carlos III), European Community's Seventh Framework Programme FP7-2007-2013 (Grant HEALTH-F2-2011-256986) and Junta de Castilla y León (CSI052A11-2, GR15-Experimental Therapeutics and Translational Oncology Program, Biomedicine Project 2009 and Biomedicine Project 2010-2011). CG is supported by the Ramón y Cajal Program from the Ministerio de Ciencia e Innovación of Spain.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Rights and permissions
About this article
Cite this article
Gajate, C., Matos-da-Silva, M., Dakir, EH. et al. Antitumor alkyl-lysophospholipid analog edelfosine induces apoptosis in pancreatic cancer by targeting endoplasmic reticulum. Oncogene 31, 2627–2639 (2012). https://doi.org/10.1038/onc.2011.446
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2011.446
- Springer Nature Limited
Keywords
This article is cited by
-
Neutrophils drive endoplasmic reticulum stress-mediated apoptosis in cancer cells through arginase-1 release
Scientific Reports (2021)
-
Induction of endoplasmic reticulum stress by aminosteroid derivative RM-581 leads to tumor regression in PANC-1 xenograft model
Investigational New Drugs (2019)
-
Induction of ER and mitochondrial stress by the alkylphosphocholine erufosine in oral squamous cell carcinoma cells
Cell Death & Disease (2018)
-
The alkyllysophospholipid edelfosine enhances TRAIL-mediated apoptosis in gastric cancer cells through death receptor 5 and the mitochondrial pathway
Tumor Biology (2016)
-
Synergistic cytotoxicity of gemcitabine, clofarabine and edelfosine in lymphoma cell lines
Blood Cancer Journal (2014)